Amentoflavone Enhances the Anti-tumor Activity of Regorafenib by Promoting Apoptosis and Inhibiting NF-κB–mediated Metastasis in Hepatocellular Carcinoma
Amentoflavone potentiates regorafenib's anti-tumor effects in HCC by promoting apoptosis and blocking NF-κB-mediated metastatic signaling, supporting its use as a safe and effective adjuvant strategy.
Authors
- Fei‐Ting Hsu (ORCID: https://orcid.org/0000-0002-2153-340X)
- Chia‐Jung Tsai (ORCID: https://orcid.org/0000-0003-1603-6879)
- Rong‐Fong Lin
- KUANG-HSUAN LIN
- Ying‐Tzu Chen
- Yu‐Cheng Kuo
- Cheng‐Tau Su
Institutions
- Ministry of Health and Welfare (KR)
- National Yang Ming Chiao Tung University (TW)
- Kaohsiung Medical University (TW)
- China Medical University (TW)
- National Central University (TW)
- Chang Bing Show Chwan Memorial Hospital (TW)
- China Medical University Hospital (TW)
- Central Taiwan University of Science and Technology (TW)
- I-Shou University (TW)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/anticanres.17669
- Citations
- 3
- Primary Topic
- Biological Activity of Diterpenoids and Biflavonoids
- Type
- article
- Field-Weighted Citation Impact
- 2.42